SCHEMBL7940689

SCHEMBL7940689

CN1C2CCC1CC(Sc1ccc(F)cc1)C2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 5/20 0.50
SLC6A2 P23975 5/20 0.50
SLC6A3 Q01959 4/20 0.50
SLC6A4 P31645 4/20 0.50
DRD3 P35462 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
TSHR P16473 1/20 0.50
CYP2C19 P33261 1/20 0.50
HRH1 P35367 1/20 0.50
CHRM2 P08172 1/20 0.49
ADRA2A P08913 1/20 0.49
DRD2 P14416 1/20 0.49
ADRA2B P18089 1/20 0.49
ADRA2C P18825 1/20 0.49
CHRM3 P20309 1/20 0.49
DRD5 P21918 1/20 0.49
HRH2 P25021 1/20 0.49
ADRA1D P25100 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5636307 0.83 SLC6A2 (0.40) SLC6A2SLC6A3SLC6A4HTR6
SCHEMBL5636304 0.83 SLC6A2 (0.40) SLC6A2SLC6A3SLC6A4HTR6
SCHEMBL7940536 0.83 SLC6A3 (0.50) CHRM1SLC6A2SLC6A3SLC6A4DRD3
SCHEMBL5634899 0.82 SLC6A2 (0.50) CHRM1SLC6A2SLC6A3SLC6A4DRD3
SCHEMBL5634904 0.82 SLC6A2 (0.50) CHRM1SLC6A2SLC6A3SLC6A4DRD3
SCHEMBL5636868 0.80 SLC6A2 (0.45) CHRM1SLC6A2SLC6A3SLC6A4DRD3
SCHEMBL4475967 0.80 SLC6A3 (0.47) CHRM1SLC6A2SLC6A3SLC6A4CHRM2
SCHEMBL5635722 0.80 SLC6A3 (0.47) CHRM1SLC6A2SLC6A3SLC6A4CHRM2
SCHEMBL14573386 0.80 SLC6A2 (0.45) CHRM1SLC6A2SLC6A3SLC6A4DRD3
SCHEMBL6451536 0.79 GAA (0.54) CHRM1SLC6A2SLC6A3SLC6A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6258827-B1 HYDROXYAROMATIC HETEROCYCLIC ALKANOLS AND LEVODOPA PFIZER INC. 2001-07-10 US disclosed
US-6046213-A Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivatives PFIZER INC. (US) 2000-04-04 US disclosed
EP-0828513-A2 COMBINATIONS FOR THE TREATMENT OF PARKINSONISM CONTAINING SELECTIVE NMDA ANTAGONISTS PFIZER INC. (US) 1998-03-18 EP disclosed
EP-0777652-A1 NEUROPROTECTIVE 3-(PIPERIDINYL-1)-CHROMAN-4,7-DIOL AND 1-(4-HYDROPHENYL)-2-(PIPERIDINYL-1)-ALKANOL DERIVATIVES PFIZER INC. (US) 1997-06-11 EP disclosed
WO-1996037226-A2 COMBINATIONS FOR THE TREATMENT OF PARKINSONISM CONTAINING SELECTIVE NMDA ANTAGONISTS PFIZER INC. (US) 1996-11-28 WO disclosed
WO-1996006081-A1 NEUROPROTECTIVE 3-(PIPERIDINYL-1)-CHROMAN-4,7-DIOL AND 1-(4-HYDROPHENYL)-2-(PIPERIDINYL-1)-ALKANOL DERIVATIVES PFIZER INC. (US) 1996-02-29 WO disclosed